BioSpace News Archive

Tenax Therapeutics, Inc. announced the pricing of a public offering of 1,600,000 shares of its common stock and warrants to purchase up to 3,200,000 shares of its common stock at a purchase price of $5.65 per share and associated Common Warrant.

Omnicell, Inc. today announced results for its fiscal year and fourth quarter ended December 31, 2023.

ScribeEMR, a leading provider of real-time remote medical scribe services, is now the “Best in KLAS for Virtual Scribing Services” provider according to the prestigious

Cadrenal Therapeutics, Inc. today announced the appointment of Jeff Cole to the newly created position of Chief Operating Officer.

BIOTRONIK is proud to introduce the Micro Rx™ catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions.

Inspira Technologies OXY BHN Ltd. has announced the signing of a non-binding Letter of Intent (LOI) with Shamir Medical Center (Assaf Harofeh), a renowned healthcare institution in central Israel.

Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer .

GE HealthCare and MedQuest Associates announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest that are needed to optimize multi-site outpatient imaging networks for success.

Premier Radiology Services, LLC is pleased to announce the acquisition of Specialists in Diagnostic Imaging, LLC.

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2023 financial results and provide a corporate update on February 15, 2024.